Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system

Colloids and Surfaces B: Biointerfaces

Volumn 95, Issue , 2012, Pages 162-169

  Hu, Chunhui ^a   Feng, Hanzhou ^a   Zhu, Chunyan ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

Alginate; Biodegradable polymers; Controlled release; Drug delivery system; Microspheres; PLGA

Indexed keywords

CONTROLLED RELEASE; DELIVERY SYSTEMS; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG RELEASE STUDY; IN-SITU; IN-VITRO; IN-VIVO; INTERVENTIONAL; MEAN DIAMETER; MINIMUM INHIBITORY CONCENTRATION; PARTICLE DISTRIBUTIONS; PLGA; PLGA MICROSPHERES; SODIUM ALGINATES; SOLVENT EVAPORATION METHOD;

ALGINATE; BIODEGRADABLE POLYMERS; DRUG DELIVERY; PATIENT TREATMENT;

MICROSPHERES;

ALGINIC ACID; MICROSPHERE; POLYGLACTIN; RIFAMPICIN;

ADHESION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MIXTURE; DRUG RETENTION; DRUG SYNTHESIS; DRUG TISSUE LEVEL; EVAPORATION; FLUORESCENCE IMAGING; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; LUNG; LUNG LAVAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SOLVENT EVAPORATION; TUBERCULOSIS;

ALGINATES; ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; GELS; GLUCURONIC ACID; HEXURONIC ACIDS; LACTIC ACID; MALE; MICE; MICE, NUDE; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; RIFAMPIN; SURFACE PROPERTIES;

EID: 84860576610     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.02.030     Document Type: Article

References (48)

1. Global Tuberculosis Control 2010, World Health Organization.
2. Makino K., Nakajima T., Shikamura M., Ito F., Ando S., Kochi C., Inagawa H., Soma G., Terada H. Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin. Colloid Surf. B: Biointerfaces 2004, 36:35-42.
3. Sree H., Chandramouli R., Shobha R. Ofloxacin targeting to lungs by way of microspheres. Int. J. Pharm. 2009, 380:127-132.
4. Tseng C.L., Wang T.W., Dong G.C., Wu S.Y.H., Young T.H., Shieh M.J., Lou P.J., Lin F.H. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 2007, 28:3996-4005.
5. Chono S., Li S.D., Conwell C.C., Huang L. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. J. Control. Release 2008, 131:64-69.
6. Vyas S.P., Quraishi S., Gupta S., Jaganathan K.S. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int. J. Pharm. 2005, 296:12-25.
7. Torchilin V.P. Targeting of drugs and drug carriers within the cardiovascular system. Adv. Drug Deliv. Rev. 1995, 17:75-101.
8. Bar J., Herbst R.S., Onn A. Targeted drug delivery strategies to treat lung metastasis. Expert Opin. Drug Deliv. 2009, 6:1003-1016.
9. Zhang J., Li Q., Bai C., Han Y., Huang Y. Inhalation of TGF-[beta]1 antibody: a new method to inhibit the airway stenosis induced by the endobronchial tuberculosis. Med. Hypotheses 2009, 73:1065-1066.
10. Liebler J.M., Markin C.J. Fiberoptic bronchoscopy for diagnosis and treatment. Crit. Care Clin. 2000, 16:83-100.
11. Jones D.S., Woolfson A.D., Brown A.F., O'Neill M.J. Mucoadhesive, syringeable drug delivery systems for controlled application of metronidazole to the periodontal pocket: in vitro release kinetics, syringeability, mechanical and mucoadhesive properties. J. Control. Release 1997, 49:71-79.
12. Jeong B., Kim S.W., Bae Y.H. Thermosensitive sol-gel reversible hydrogels. Adv. Drug. Deliv. Rev. 2002, 54:37-51.
13. Alipour S., Montaseri H., Tafaghodi M. Preparation and characterization of biodegradable paclitaxel loaded alginate microparticles for pulmonary delivery. Colloid Surf. B: Biointerfaces 2010, 81:521-529.
14. Mahmoodi N.M., Hayati B., Arami M., Bahrami H. Preparation, characterization and dye adsorption properties of biocompatible composite (alginate/titania nanoparticle). Desalination 2011, 275:93-101.
15. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 1997, 28:5-24.
16. Astete C.E., Sabliov C.M. Synthesis and characterization of PLGA nanoparticles. J. Biomater. Sci. Polym. Ed. 2006, 17:247-289.
17. Ito F., Fujimori H., Honnami H., Kawakami H., Kanamura K., Makino K. Effect of polyethylene glycol on preparation of rifampicin-loaded PLGA microspheres with membrane emulsification technique. Colloid Surf. B: Biointerfaces 2008, 66:65-70.
18. Doan T.V.P., Couet W., Olivier J.C. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int. J. Pharm. 2011, 414:112-117.
19. Hirota K., Hasegawa T., Nakajima T., Inagawa H., Kohchi C., Soma G., Makino K., Terada H. Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis. J. Control. Release 2010, 142:339-346.
20. O'Donnell P.B., McGinity J.W. Preparation of microspheres by the solvent evaporation technique. Adv. Drug Deliv. Rev. 1997, 28:25-42.
21. Tomoda K., Makino K. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres. Colloid Surf. B: Biointerfaces 2007, 55:115-124.
22. Miyazaki S., Kubo W., Attwood D. Oral sustained delivery of theophylline using in-situ gelation of sodium alginate. J. Control. Release 2000, 67:275-280.
23. Edsman K., Carlfors J., Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci. 1998, 6:105-112.
24. Chang J.Y., Oh Y.K., Choi H.G., Kim Y.B., Kim C.K. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int. J. Pharm. 2002, 241:155-163.
25. Ur-Rehman T., Tavelin S., Grobner G. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels. Int. J. Pharm. 2011, 409:19-29.
26. Kwon I.C. Chitosan-based nanoparticles for cancer therapy; tumor specificity and enhanced therapeutic efficacy in tumor-bearing mice. J. Control. Release 2008, 132:69-70.
27. Zhan C., Gu B., Xie C., Li J., Liu Y., Lu W. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J. Control. Release 2010, 143:136-142.
28. Wen Z., Yan Z., Hu K., Pang Z., Cheng X., Guo L., Zhang Q., Jiang X., Fang L., Lai R. Odorranalectin-conjugated nanoparticles: preparation, brain delivery and pharmacodynamic study on Parkinson's disease following intranasal administration. J. Control. Release 2011, 151:131-138.
29. Milane L., Duan Z.F., Amiji M. Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotropic animal model of multi-drug resistant breast cancer. Nanomed. Nanotechnol. 2011, 7:435-444.
30. Sugahara K., Ezaki K., Kaneko T., Morioka T., Maeda H. Studies of the lungs in diabetes mellitus. II. Phospholipid analyses on the surfactant from broncho-alveolar lavage fluid of alloxan-induced diabetic rats. Biochem. Biophys. Res. Commun. 1981, 98:163-168.
31. Sutinen R., Laasanen V., Paronen P., Urtti A. pH-controlled silicone microspheres for controlled drug delivery. J. Control. Release 1995, 33:163-171.
32. ®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J. Control. Release 2001, 76:239-254.
33. Zhang Y.L., Wei W., Lv P.P., Wang L.Y., Ma G.H. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin. Eur. J. Pharm. Biopharm. 2011, 77:11-19.
34. Ito F., Honnami H., Kawakami H., Kanamura K., Makino K. Preparation and properties of PLGA microspheres containing hydrophilic drugs by the SPG (shirasu porous glass) membrane emulsification technique. Colloid Surf. B: Biointerfaces 2008.
35. Rawat A., Burgess D.J. Effect of physical ageing on the performance of dexamethasone loaded PLGA microspheres. Int. J. Pharm. 2011, 415:164-168.
36. Kubo W., Miyazaki S., Attwood D. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations. Int. J. Pharm. 2003, 258:55-64.
37. Zhang C.X., Zhang W.T., Wang D.K., Zhong J.J., Xu S. Novel drug delivery system-advance in research of in situ gel. Chin. Hosp. Pharm. J. 2006, 26:459-461.
38. Ganguly S., Dash A.K. A novel in situ gel for sustained drug delivery and targeting. Int. J. Pharm. 2004, 276:83-92.
39. Mayol L., Quaglia F., Borzacchiello A., Ambrosio L., La Rotonda M.I. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Eur. J. Pharm. 2008, 70:199-206.
40. Kheirolomoom A., Kruse D.E., Qin S., Watson K.E., Lai C.Y., Young L.J.T., Cardiff R.D., Ferrara K.W. Enhanced in vivo bioluminescence imaging using liposomal luciferin delivery system. J. Control. Release 2010, 141:128-136.
41. Wang K., Purushotham S., Lee J.Y., Na M.H., Park H., Oh S.J., Park R.W., Park J.Y., Lee E., Cho B.C., Song M.N., Baek M.C., Kwak W., Yoo J., Hoffman A.S., Oh Y.K., Kim I.S., Lee B.H. In vivo imaging of tumor apoptosis using histone H1-targeting peptide. J. Control. Release 2010, 148:283-291.
42. Guo L.R., Fan L., Pang Z.Q., Ren J.F., Ren Y.L., Li J.W., Chen J., Wen Z.Y., Jiang X.G. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes. J. Control. Release 2011, 154:93-102.
43. Hansch A., Hilger I., Frey O., Sauner D., Gajda M., Haas M., Malich A., Böttcher J., Bräuer R., Kaiser W.A. Near-infrared imaging of flare-up arthritis with native fluorochrome Cy5.5 and albumin-bound Cy5.5. J. Exp. Anim. Sci. 2006, 43:129-139.
44. Soley M., Alemany M. A rapid method for the estimation of amino acid concentration in liver tissue. J. Biochem. Biophys. Methods 1980, 2:207-211.
45. North J.A., Tappel A.L. Measuring the oxidation of heme compounds in heart homogenates from rats supplemented with dietary antioxidants. Free Radic. Biol. Med. 1997, 22:175-184.
46. Bae S.K., Kim E.J., Kwon J.W., Kim W.B., Lee M.G. High-performance liquid chromatographic analysis of DA-7867, a new oxazolidinone, in human plasma and urine and in rat tissue homogenates. J. Chromatogr. B 2003, 794:397-403.
47. Pothiwong W., Laorpaksa A., Pirarat N., Sirisawadi S., Intarapanya J., Jianmongkol S. Autoxidation of brain homogenates from various animals as measured by thiobarbituric acid assay. J. Pharmacol. Toxicol. 2007, 56:336-338.
48. Baykam N., Esener H., Ergönül ö., Eren S., çelikbas A.K., Dokuzoguz B. In vitro antimicrobial susceptibility of Brucella species. Int. J. Antimicrob. Agents 2004, 23:405-407.